Background: As the outbreak of COVID-19 has accelerated, an urgent need for finding strategies to combat the virus is growing. Thus, gaining more knowledge on the pathogenicity mechanism of SARS-CoV-2, i.e. the causing agent of COVID-19, and its interaction with the immune system is of utmost importance. Although this novel virus is not well known yet, its structural and genetic similarity with SARS-CoV as well as the comparable pattern of age-mortality relations suggest that some previous findings on SARS could be applicable for COVID-19. Objective: The aim of this study was to investigate the most important signaling pathways activated by coronaviruses to better understand the viral pathogenesis and host immune responses. Method: Here, a systems biology study was conducted on a SARS database. It was followed by a literature review on the cognate subject. Results: It was proved that interferons may possess a crucial role in the defense against coronavirus diseases. The literature supported the validity of the employed approach and the notion that interferon induction could play a key role in the body defense against coronavirus infections. Conclusion: Altogether, administration of interferons or interferon-inducing agents in a prophylactic manner or at the early stages of the disease, could mimic the effective antiviral responses against SARS-CoV-2 and reduce the disease severity. At later stages of the disease, however, the balance of the immune reactions would be disrupted and the responses would shift toward immunopathogenic over-reactions, which could be exacerbated by the interferon usage. Moderating the activity of the immune system by anti-inflammatory agents, might be the optimum approach in such conditions.
13 November 2020 in Human Vaccines & Immunotherapeutics
No proven remedy is identified for COVID-19 yet. SARS-CoV-2, the viral agent, is recognized by some endosomal and cytosolic receptors following cell entry, entailing innate and adaptive immunity stimulation, notably through interferon induction. Impairment in immunity activation in some patients, mostly elderlies, leads to high mortalities; thus, promoting immune responses may help. BCG vaccine is under investigation to prevent COVID-19 due to its non-specific effects on the immune system. However, other complementary immune-induction methods at early stages of the disease may be needed. Here, the potentially preventive immunologic effects of BCG and influenza vaccination are compared with the immune response defects caused by aging and COVID-19. BCG co-administration with interferon-α/-β, or influenza vaccine is suggested to overcome its shortcomings in interferon signaling against COVID-19. However, further studies are highly recommended to assess the outcomes of such interventions considering their probable adverse effects especially augmented innate immune responses and overproduction of proinflammatory mediators.
Some studies have investigated the potential role of transposable elements (TEs) in COVID-19 pathogenesis and complications. However, to the best of our knowledge, there is no study to examine the possible association of TE expression in cell functions and its potential role in COVID-19 immune response at the single-cell level. In this study, we reanalyzed single-cell RNA seq data of bronchoalveolar lavage (BAL) samples obtained from six severe COVID-19 patients and three healthy donors to assess the probable correlation of TE expression with the immune responses induced by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in COVID-19 patients. Our findings indicate that the expansion of myeloid-derived suppressor cells (MDSCs) may be a characteristic feature of COVID-19. Additionally, a significant increase in TE expression in MDSCs was observed. This upregulation of TEs in COVID-19 may be linked to the adaptability of these cells in response to their microenvironments. Furthermore, it appears that the identification of overexpressed TEs by pattern recognition receptors (PRRs) in MDSCs may enhance the suppressive capacity of these cells. Thus, this study emphasizes the crucial role of TEs in the functionality of MDSCs during COVID-19.
Background Multiple sclerosis (MS) is a chronic and often immune-mediated demyelinating disease with no definitive treatment. Transposable elements (TEs) are receiving increasing attention as potential contributors to neurodegenerative diseases. However, to the best of our knowledge, no studies have examined the possible association of TE expression and its potential role in MS pathogenesis at the single-cell level. Results In this study, we reanalyzed single-cell RNA sequencing data from human cerebrospinal fluid (CSF) samples. Our results revealed that TEs are overexpressed in a cluster of cells annotated as innate lymphoid cells (ILCs). Furthermore, enrichment analysis of the associated transcription factors (TFs) with highly upregulated TEs in ILCs revealed the relevance of these TFs to immune pathways and cis-regulatory regions in DNA. Conclusions We propose that upregulated TEs in ILCs are consistent with the plasticity of these cells, as TEs can insert themselves in coding or regulatory regions of immune-related genes and represent themselves as immune-related TF binding sites. We also hypothesize that ILCs with overexpressed TEs could present TE-derived antigens, potentially reactivating T cell-mediated immunity in the central nervous system (CNS) of MS patients. Therefore, this study indicates a possible mechanism involving TEs in ILC plasticity and their potential role in MS pathogenicity. Additionally, we suggest that repurposing nucleoside reverse transcriptase inhibitors (NRTIs) or developing new high-efficacy NRTIs could be a feasible approach to treating MS.